P. Payette

发表

Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene.

B. Kennedy, W. Cromlish, M. Gresser, 1999, Science.

A Natural Disruption of the Secretory Group II Phospholipase A2 Gene in Inbred Mouse Strains (*)

J. Mudgett, W. Cromlish, D. Rancourt, 1995, The Journal of Biological Chemistry.

Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities

P. Payette, Marion Jurk, A. Krieg, 2004, European journal of immunology.

The YRD Motif Is a Major Determinant of Substrate and Inhibitor Specificity in T-cell Protein-tyrosine Phosphatase*

C. Bayly, C. Desponts, E. Asante-Appiah, 2001, The Journal of Biological Chemistry.

Testing of CpG-Optimized Protein and DNA Vaccines against the Hepatitis B Virus in Chimpanzees for Immunogenicity and Protection from Challenge

M. Shapiro, R. Purcell, P. Payette, 2006, Intervirology.

Vasocontractile muscarinic M1 receptors in cat cerebral arteries: pharmacological identification and detection of mRNA.

E. Hamel, P. Payette, F. Dauphin, 1991, European journal of pharmacology.

DNA-based vaccination against hepatitis C virus (HCV): effect of expressing different forms of HCV E2 protein and use of CpG-optimized vectors in mice.

R. Purcell, J. Bukh, X. Forns, 2002, Vaccine.

Vaccination of Chimpanzees With Plasmid DNA Encoding the Hepatitis C Virus (HCV) Envelope E2 Protein Modified the Infection After Challenge With Homologous Monoclonal HCV

S. Emerson, R. Purcell, J. Bukh, 2000, Hepatology.

Selective inhibitors of COX-2.

J. Falgueyret, B. Kennedy, C. Chan, 1995, Agents and actions. Supplements.

Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll‐like receptor 9 dependent T helper type 2 biased immune stimulation

P. Payette, Marion Jurk, A. Krieg, 2004, Immunology.

Human cytosolic phospholipase A2 expressed in insect cells is extensively phosphorylated on Ser-505.

B. Kennedy, W. Cromlish, P. Payette, 1995, Biochimica et biophysica acta.

CpG Oligodeoxynucleotides with Hepatitis B Surface Antigen (HBsAg) for Vaccination in HBsAg-Transgenic Mice

P. Payette, H. Davis, P. Tiollais, 2001, Journal of Virology.

in HBsAg-Transgenic Mice B Surface Antigen ( HBsAg ) for Vaccination CpG Oligodeoxynucleotides with Hepatitis

P. Payette, H. Davis, P. Tiollais, 2001 .

High-level expression of active human cyclooxygenase-2 in insect cells.

M. Percival, B. Kennedy, W. Cromlish, 1994, Archives of biochemistry and biophysics.

Structure based design of a series of potent and selective non peptidic PTP-1B inhibitors.

C. Bayly, E. Asante-Appiah, Y. Boie, 2004, Bioorganic & medicinal chemistry letters.

Development and validation of an intact cell assay for protein tyrosine phosphatases using recombinant baculoviruses.

B. Kennedy, W. Cromlish, P. Payette, 1999, Biochemical pharmacology.

Mechanism of Inhibition of Protein-tyrosine Phosphatases by Vanadate and Pervanadate*

M. Gresser, C. Ramachandran, P. Payette, 1997, The Journal of Biological Chemistry.

Delineation of a CpG Phosphorothioate Oligodeoxynucleotide for Activating Primate Immune Responses In Vitro and In Vivo1

R. Purcell, P. Payette, A. Krieg, 2000, The Journal of Immunology.

Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA.

P. Payette, H. Davis, M. McCluskie, 2002, FEMS immunology and medical microbiology.

Expression and pharmacological characterization of the human M1 muscarinic receptor in Saccharomyces cerevisiae

M. Whiteway, P. Payette, M. Dennis, 1990, FEBS letters.

Refinement of an in vitro cell model for cytochrome P450 induction.

B. Kennedy, T. Rushmore, P. Payette, 1998, Drug metabolism and disposition: the biological fate of chemicals.

Functional identification of the active-site nucleophile of the human 85-kDa cytosolic phospholipase A2.

B. Kennedy, W. Cromlish, P. Payette, 1996, Biochemistry.

This information is current as Immune Responses In Vitro and In Vivo Oligodeoxynucleotide for Activating Primate Delineation of a CpG Phosphorothioate

R. Purcell, P. Payette, H. Davis, 2000 .

Structure of protein tyrosine phosphatase 1B in complex with inhibitors bearing two phosphotyrosine mimetics.

B. Kennedy, Q. Ye, D. Waddleton, 2001, Journal of medicinal chemistry.